A
The startup develops orally administered small molecule therapeutics and heterocyclic derivative compounds specifically for treating hereditary angioedema and other rare diseases. By providing targeted pharmaceutical compositions, the company enables clinicians to effectively manage and treat these challenging medical conditions.
City of New York, United States
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops orally administered small molecule therapeutics and heterocyclic derivative compounds specifically for treating hereditary angioedema and other rare diseases. By providing targeted pharmaceutical compositions, the company enables clinicians to effectively manage and treat these challenging medical conditions.